Article

Integrative services can be found in the community

Author(s):

Jon Garinn blog image

We've had a handful of responses to our recent feature on integrative therapies, including opponents who insist that integrative oncology is "sham science" and proponents who want to make integrative techniques more widely available. Olivia Lawrence, an enthusiastic proponent, is responsible for community outreach at Cornucopia Cancer Support Center, based on Durham, N.C. She wrote to tell us that comprehensive cancer centers, such as the ones we referenced in our story, are not the only organizations offering integrative services. Cornucopia, like other nonprofit organizations throughout the country, offers integrative therapies free of charge to patients, survivors and caregivers.She says because Cornucopia is a non-clinical support center, it offers an environment that many participants prefer to a hospital setting--one that better facilitates peer-to-peer support. She emphasizes that Cornucopia's providers have the necessary licenses and certifications, and all are trained in how to work with patients who have particular treatment challenges.Cornucopia has identified 89 nonprofit cancer support organizations that provide no- or low-cost integrative services. The organization also offers an extensive list of online resources. If you would like to know whether a support organization offers integrative services in your area, check here for more information.

Related Videos
Image of man with black hair.
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Related Content